In collaboration with CDC, blood collection agencies are conducting ongoing surveillance for human immunodeficiency virus type 2 (HIV-2) infection among U.S. blood donors. Through December 1989, no blood donors with HIV-2 infection had been detected. This report summarizes findings of recent HIV-2 surveillance by the American Red Cross Blood Services (ARCBS) and the New York Blood Center (NYBC).
The week of October 22-26, 1990, is National Adult Immunization Awareness Week. This event, observed annually during the last week in October, emphasizes the importance of appropriately immunizing all adults. Immunization programs in the United States have markedly reduced the occurrence of vaccine-preventable diseases in children; however, adults who were not infected or immunized during childhood may be at increased risk for these diseases and their complications.
In January 1990, a health department in the United States received a report of human immunodeficiency virus type 1 (HIV-1) infection in a woman who had been artificially inseminated with semen from her HIV-1-infected, hemophilic husband. The man had tested positive for HIV-1 antibody in 1985, but his wife had been negative for HIV-1 antibody yearly since 1985, most recently in December 1988. In August, October, and December 1989, the woman was inseminated with semen from her husband.
Antimicrobial resistance in Neisseria gonorrhoeae has developed to each of the agents that have been recommended for gonorrhea therapy. As a result, a well-standardized laboratory method to monitor the susceptibilities of gonococcal isolates has been recommended by the National Committee for Clinical Laboratory Standards (NCCLS). The NCCLS recently completed a multicenter study to standardize disk diffusion (and agar dilution) susceptibility tests for N. gonorrhoeae and to establish interpretive criteria and quality-control guidelines.
CDC provides support to 63 human immunodeficiency virus (HIV) prevention programs through health departments in 50 states, four cities, seven territories, the District of Columbia, and Puerto Rico. Each calendar quarter, the 63 programs report to CDC aggregate data regarding the number of 1) pretest counseling sessions, HIV-antibody tests, positive tests, and post-test counseling sessions, by type of testing site; . . . .
MMWR Weekly, February 23, 1990 / 39(7);110-112,117-119
Currently about 1 million persons in the United States are infected with human immunodeficiency virus (HIV). The number of cases of acquired immunodeficiency syndrome (AIDS) will continue to increase over the next 4 years, with a projected 52,000-57,000 cases to be diagnosed in 1990. These estimates are based on AIDS case surveillance data, HIV seroprevalence data, and information provided by epidemiologists, statisticians, and mathematical modelers who attended a workshop on October 31-November 1, 1989, in Atlanta.
During 1989, state and territorial health departments reported 35,238 cases (14.0 per 100,000 population) of acquired immunodeficiency syndrome (AIDS) to CDC. Rates (reported cases per 100,000 population) were highest for blacks and Hispanics; for persons 30-39 years of age; in the Northeast region and in U.S. territories (primarily reflecting rates in Puerto Rico); in the largest metropolitan areas; and for men (Table 1).
MMWR Recommendations and Reports, January 26, 1990 / 39(RR01);1-14
CDC has issued guidelines to reduce the risk of human immunodeficiency virus (HIV) infection among health-care workers, emergency-response and public-safety workers, and others who might be exposed to HIV while performing job duties. The safety practices outlined in these guidelines remain the primary means of preventing occupational acquisition of HIV infection.
This information is designed to support, not replace, the relationship that exists between you and your doctor.